SCHEMBL26469193

SCHEMBL26469193

CC(C)CNC(=O)c1csc(Br)c1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.56
KMT2A Q03164 1/20 0.56
HSD17B10 Q99714 1/20 0.56
KDM4E B2RXH2 3/20 0.52
LMNA P02545 2/20 0.52
HTT P42858 1/20 0.52
HPGD P15428 6/20 0.50
MLYCD O95822 1/20 0.46
MAPT P10636 1/20 0.46
NPSR1 Q6W5P4 2/20 0.45
ALDH1A1 P00352 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
RAB9A P51151 3/20 0.45
NPC1 O15118 1/20 0.45
CNR2 P34972 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
RXFP1 Q9HBX9 1/20 0.41
USP2 O75604 1/20 0.39
TP53 P04637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7217724 0.83 L3MBTL1 (0.48) GAAKMT2AHSD17B10LMNAHTT
SCHEMBL25233005 0.78 HPGD (0.46) GAAKDM4EHTTHPGDMAPT
SCHEMBL2908793 0.78 HSD17B10 (0.78) GAAKMT2AHSD17B10KDM4ELMNA
SCHEMBL1750114 0.77 HDAC8 (0.45) KMT2ALMNAHTTHPGDMAPT
SCHEMBL2837167 0.77 ALDH1A1 (0.53) GAAHSD17B10KDM4ELMNAHTT
SCHEMBL27201546 0.74 USP2 (0.57) GAAKMT2AHSD17B10KDM4ELMNA
SCHEMBL17865783 0.74 MLYCD (0.73) GAAKMT2AHSD17B10KDM4ELMNA
SCHEMBL889069 0.74 MLYCD (0.63) GAAKMT2AHSD17B10KDM4ELMNA
SCHEMBL1919666 0.72 HSD17B10 (0.54) GAAKMT2AHSD17B10KDM4ELMNA
SCHEMBL31055430 0.72 KMT2A (0.78) GAAKMT2AHSD17B10KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11641857-B2 Unusually potent ABA receptor pan-antagonists THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11641857-B2 Unusually potent ABA receptor pan-antagonists AAK1, ATP5PO, BROX GAA 1121/4885KMT2A 3307/4885HSD17B10 1719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.